|
1. |
OBLITERATIVE AIRWAY DISEASE AFTER HETEROTOPIC TRACHEAL XENOTRANSPLANTATIONPathogenesis and Prevention Using New Immunosuppressive Agents |
|
Transplantation,
Volume 64,
Issue 3,
1997,
Page 373-383
Reichenspurner1,2 Hermann,
Soni1 Vipal,
Nitschke1 Michael,
Berry3 Gerald,
Brazelton1 Timothy,
Shorthouse1 Randi,
Huang1 Xinfan,
Reitz2 Bruce,
Morris1,4 Randall,
Preview
|
|
摘要:
Background.The purpose of this study was to investigate whether obliterative bronchiolitis might occur after xenogenic pulmonary transplantation. A model for obliterative airway disease (OAD) after tracheal allograft transplantation in the rat undergoes tracheal obliteration with histologic features characteristic of obliterative bronchiolitis in human lung transplant recipients. Using this model, the pathogenesis of OAD and its prevention with immunosuppressive drugs was studied in rat recipients of hamster tracheal grafts.Methods.Tracheae from 30 hamsters (xenografts) or 23 Brown-Norway rats (allografts) were implanted and wrapped in the greater omentum of untreated Lewis rats. The grafts were removed on day 1, 3, 7, 14, 21, or 28 after transplantation and stained with hematoxylin and eosin and Masson's trichrome and by immunohistochemistry and immunofluorescence (IFL) techniques. In addition, 25 recipients were treated with cyclosporine (CsA, 10 mg/kg p.o.), leflunomide (LFM, 20 mg/kg p.o.), or rapamycin (RPM, 6 mg/kg i.p.) for 14 or 21 days (5 animals per treatment group). Visual and morphometric analyses were used to evaluate the extent of airway obliteration, luminal coverage by respiratory or flattened cuboidal epithelium, and extent and density of peritracheal cellular inflammation.Results.In all xenografts, a neutrophilic infiltration of the mucosa and submucosa was observed from day 1 until day 14 and was associated with complete loss of tracheal epithelium by day 14. A marked peritracheal mononuclear cellular infiltrate mixed with plasma cells and eosinophils was seen on days 7 and 14. Both the extent of peritracheal inflammation and the density of the mononuclear cell infiltrate were significantly increased in xenograft tracheae when compared with the allografts. Tracheal obliteration began on day 14 and reached a maximum of 43% on day 21 with evidence of intraluminal fibrosis. In contrast to IFL of allografts, IFL of xenografts demonstrated marked deposition of rat immunoglobulin in the peritracheal tissue on days 7 and 14. The effects of treatment with immunosuppressive drugs on tracheal graft narrowing and protection of respiratory epithelium were as follows: After 14 days of treatment, the percentage of tracheal graft narrowing was 12%, 23%, and 19% in the no treatment, CsA, and LFM groups, respectively; the percentage of respiratory epithelium at 14 days was 0%, 21%, and 95%. After 21 days of treatment, the percentage of tracheal graft narrowing was 43%, 49%, 12%, and 5% for the no treatment, CsA, LFM, and RPM groups, respectively; the percentage of respiratory epithelium at 21 days was 0%, 39%, 86%, and 0%. Using computerized morphometry, the extent and densities of the peritracheal cellular infiltrates were significantly reduced in LFM- and CsA-treated groups when compared with untreated xenograft controls. LFM and RPM, but not CsA, significantly reduced the degree of luminal obliteration compared with no treatment (P<0.05). LFM and, to a lesser extent, CsA were able to prevent the loss of normal respiratory epithelium. Analysis by IFL revealed a marked decrease in rat immunoglobulin deposition in xenografts from LFM- and RPM-treated groups compared with xenografts from CsA-treated or untreated rats.Conclusions.(1) OAD occurs not only after tracheal allotransplantation but also after xenotransplantation. (2) Subepithelial infiltration of neutrophils and the appearance of plasma cells and eosinophils in the peritracheal infiltrates distinguished the histology of rejected xenografts from allografts. (3) Antibody deposition was detected by IFL only in xenografts. (4) Treatment with LFM or RPM significantly decreased the severity of luminal obliteration. Importantly, LFM also prevented the loss of respiratory epithelium.
ISSN:0041-1337
出版商:OVID
年代:1997
数据来源: OVID
|
2. |
IMMUNOPATHOLOGICAL OBSERVATIONS AFTER XENOGENEIC LIVER PERFUSIONS USING DONOR PIGS TRANSGENIC FOR HUMAN DECAY-ACCELERATING FACTOR1,2 |
|
Transplantation,
Volume 64,
Issue 3,
1997,
Page 384-391
Pascher3 Andreas,
Poehlein3 Christian,
Storck4 Martin,
Prestel4 Roland,
Mueller-Hoecker5 Josef,
White6 David,
Abendroth4 Dietmar,
Hammer1,7 Claus,
Preview
|
|
摘要:
Background.Donor pigs transgenic for human decay-accelerating factor (hDAF) were used in a xenogeneic ex vivo liver perfusion model to study the effect of this modification on the development of hyperacute rejection.Methods.Three transgenic pigs were hepatectomized after hypothermic portal and transaortal gravity perfusion. Livers from six nontransgenic pigs served as controls. All livers were perfused for 3 hr with human blood from two donors diluted to a hematocrit of 30%. Particular importance was placed on the use of an optimal perfusion technique incorporating the floating suspension of the organs in a waterbath and intermittent external pressurization. Biochemical, physiological, and immunological parameters were assessed. Tissue specimens taken before and after perfusion were analyzed using routine histology, electron microscopy, and immunohistology.Results.Complement activation was more pronounced in the control group. AP50 and CH50 values fell to about 60% of the initial levels in control experiments, whereas they remained at 80% of the initial levels during perfusion of hDAF livers. After 180 min, pig tumor necrosis factor α levels were 7862±1645 pg/ml for unmodified livers and 2830±734 pg/ml in the hDAF group. Human tumor necrosis factor α levels were similar in both groups. Control livers showed marked morphological alterations and distinct deposition of complement factors, whereas livers expressing hDAF showed no signs of hepatocellular necrosis and almost no complement deposition beyond C3 activation.Conclusions.These results confirm that the transgenic expression of the human complement regulatory protein hDAF reduces complement activation and prevents hyperacute rejection in a xenogeneic liver perfusion model over the 3-hr evaluation period used in this study.
ISSN:0041-1337
出版商:OVID
年代:1997
数据来源: OVID
|
3. |
EFFECT OF CYTOMEGALOVIRUS ON AN EXPERIMENTAL MODEL OF CHRONIC RENAL ALLOGRAFT REJECTION UNDER TRIPLE-DRUG TREATMENT IN THE RAT1 |
|
Transplantation,
Volume 64,
Issue 3,
1997,
Page 391-398
Lautenschlager2,3 Irmeli,
Soots4 Anu,
Krogerus5 Leena,
Kauppinen4 Harri,
Saarinen6 Osmo,
Bruggeman7 Cathrien,
Ahonen4 Juhani,
Preview
|
|
摘要:
Background.Cytomegalovirus (CMV) infection is thought to be a risk factor of chronic rejection. In clinical studies and animal models, mainly concerning graft vasculopathy, CMV has been demonstrated to enhance allograft arteriosclerosis. In this study we have investigated the effect of CMV on the early inflammatory response and graft histology in an experimental model of renal transplantation in a rat strain combination that develops chronic rejection under triple-drug immunosuppression.Methods.Renal transplantations were performed in a rat strain combination of DA→BN receiving triple-drug treatment (2 mg/kg methylprednisolone, 2 mg/kg azathioprine, 5 mg/kg cyclosporine daily subcutaneously). One group of immunosuppressed animals was infected with rat CMV, the Maastricht strain (105plaque-forming units intraperitoneally), and the other group was left uninfected. As a positive control for alloresponse, one group of recipients received neither immunosuppression nor virus. Syngenic transplantations with triple-drug treatment and CMV were used as negative controls. The grafts were monitored by frequent ultrasound-guided fine-needle aspiration biopsies, and the intragraft inflammation was quantified in detail by the increment method and expressed in corrected increment units (CIU). Graft histology was performed in parallel.Results.Nonimmunosuppressed animals developed acute rejection with a high peak of inflammation (7.9±3.2 CIU), a typical blast response, and lymphocytosis followed by infiltration of macrophages and necrosis within 7 days. Triple drug-treated animals had a short, mild inflammatory response (3.3±1.4 CIU at the peak) in the graft 3-5 days after transplantation but ended up with histological changes characteristic of chronic rejection with vasculopathy and fibrosis 40-60 days later. Triple drug-treated animals with CMV demonstrated a significantly stronger inflammation (4.5±1.8 CIU,P<0.01) than those without, and lymphoid activation continued longer and was followed by infiltration of macrophages in the graft. CMV infection of the graft was demonstrated by viral culture and antigen detection. In histology, chronic rejection with intimal thickening of arteries and arterioles and medial necrosis of large arteries was seen at 14 days, ending up with remarkable graft fibrosis within 20 days after transplantation.Conclusion.CMV prolonged and increased graft inflammation and accelerated chronic rejection of renal allografts under triple-drug treatment.
ISSN:0041-1337
出版商:OVID
年代:1997
数据来源: OVID
|
4. |
INFLUENCES OF DIETARY ω-3 POLYUNSATURATED FATTY ACIDS ON THE RECOVERY OF CARDIAC AND RENAL FUNCTIONS AFTER PRESERVATION IN HYPERLIPIDEMIC RATS1 |
|
Transplantation,
Volume 64,
Issue 3,
1997,
Page 399-404
Ku2,3 Kwansong,
Oku2 Hidetaka,
Alam2 Mohammed,
Iwasaki2 Shinji,
Xu2 Gang,
Nosaka2 Seishi,
Saitoh2 Yuhei,
Hanada2 Tomoki,
Nakayama4 Kengo,
Preview
|
|
摘要:
Background.The effects of a soybean oil diet and a high-cholesterol oil (HC) diet, and an HC diet with eicosapentaenoic acid (EPA) or docosahexaenoic acid (DHA) supplementation, on basal and postpreservative cardiac function of the hearts and on postpreservative renal function of the kidneys from older rats were examined.Methods.Groups 1 through 4 of 100-week-old rats were fed either soybean oil, HC, HC with EPA, or HC with DHA, respectively, for 12 weeks. Blood was collected for analysis of plasma fatty acids, and the heart and left kidney were removed from the rat. In experiment 1, the heart was perfused on a Langendorff apparatus. After evaluation of the cardiac function of each rat, the heart was stored in histidine-tryptophanketoglutarate solution for 8 hr at 4°C. The heart was reperfused and the recovery of cardiac function was evaluated. The coronary perfusate during reperfusion was collected to measure 6-keto prostaglandin F1α and thromboxane B2. Coronary flow (CF) perfused with Krebs-Henseleit bicarbonate (KHB) solution containing 5-hydroxytryptamine (5-HT) and nitroglycerin were evaluated in the Langendorff mode with atrial pacing (330 beats/min). In experiment 2, the excised left kidney was immediately flushed and preserved with University of Wisconsin solution for 8 hr at 4°C. The kidney was then reperfused with KHB solution and renal function was evaluated.Results.The plasma and cardiac EPA levels in group 3 were significantly higher than the levels found in the other groups. The plasma and cardiac ratios of EPA to arachidonic acid were significantly higher in groups 3 and 4 than in groups 1 and 2. There were no significant differences in basal cardiac function among any of the diet-fed rats. The percentage values of the recovery of aortic flow, cardiac output (CO), and left ventricular max dp/dt in group 3 and CO in group 4 were significantly higher than in group 2. In addition, the recovery of CF in group 3 tended to be higher than in group 2 (P=0.07). The percentage values of the recovery of aortic flow, CF, CO, and left ventricular max dp/dt in group 1 were significantly lower than in the other dietary groups. CF reperfused with KHB solution containing 5-HT was significantly higher in group 3 than in groups 1 and 2. CF reperfused with KHB solution containing 5-HT was significantly higher in group 4 than in group 1. CF reperfused with KHB solution containing nitroglycerin in group 3 tended to be higher than in groups 1 and 2 (P=0.07). The thromboxame B2concentrations in the coronary perfusate during reperfusion in groups 3 and 4 were significantly lower than in groups 1 and 2. Fractional sodium reabsorption in group 3 was significantly higher than in group 2. Inulin clearance in groups 3 and 4 was significantly higher than in group 1. The postpreservative urinary flow in group 3 was significantly higher than in groups 1 and 2. The urinary flow was significantly higher in group 4 than in group 1.Conclusions.These results suggest that EPA administration may attenuate preservation and reperfusion injury and improve the recovery of cardiac and renal functions in hyperlipidemic and older rats. DHA administration may also show beneficial effects on kidney preservation in hyperlipidemic rats.
ISSN:0041-1337
出版商:OVID
年代:1997
数据来源: OVID
|
5. |
SEROTONIN AS A USEFUL PARAMETER FOR COLD AND WARM ISCHEMIC INJURY IN SMALL BOWEL TRANSPLANTATION |
|
Transplantation,
Volume 64,
Issue 3,
1997,
Page 405-410
Kaihara1 Satoshi,
Egawa Hiroto,
Inomata Yukihiro,
Uemoto Shinji,
Asonuma Katuhiro,
Tanaka Koichi,
Preview
|
|
摘要:
We investigated serotonin as a parameter of cold and warm ischemic injury prior to transplantation. Lewis rats were used as both donors and recipients, and the proximal 20 cm of jejunum served as the graft. The grafts were preserved in 4°C lactated Ringer's solution for 0, 6, 12, 18, and 24 hr after harvest for cold ischemia (n=7/group). The superior mesenteric artery was clamped for 0, 15, 30, 60, and 120 min before harvest for warm ischemia (n=7/group). The serotonin concentration was measured in the luminal effluent and the preservation solution before transplantation, and total serotonin was calculated as the sum of these amounts. Finally, transplantation was performed heterotopically. Total serotonin increased significantly with both cold and warm ischemic time (P<0.01 by analysis of variance, Fisher's PLSD); however, between 18 hr and 24 hr of cold ischemic time only, there were no significant changes. Total serotonin levels correlated well with cold and warm ischemic time, as shown by linear regression analysis (cold ischemia: R2=80.2%,P<0.01; warm ischemia: R2=92.8%,P<0.01). We established the cutoff level of total serotonin to predict the graft survival at 2200 ng, and using this critical level, graft survival was predicted by total serotonin with a sensitivity of 71.4% and a specificity of 89.8%. Immunohistochemical staining with the serotonin antibody revealed that the number of serotonin-positive cells decreased with both cold and warm ischemic time. In conclusion, serotonin is a useful parameter of cold and warm ischemic injury before transplantation and can assist in predicting graft survival.
ISSN:0041-1337
出版商:OVID
年代:1997
数据来源: OVID
|
6. |
RETRANSPLANTATION OF PATIENTS WITH SEVERE POSTTRANSPLANT HEPATITIS B IN THE FIRST ALLOGRAFT |
|
Transplantation,
Volume 64,
Issue 3,
1997,
Page 410-414
Ishitani1,2 M.,
McGory1 R.,
Dickson3 R.,
Caldwell1 S.,
Bickston1 S.,
McCullough1 C.,
Pruett1 T.,
Terrault4 N.,
Roberts4 J.,
Ascher4 N.,
Wright4 T.,
Lake4 J.,
Preview
|
|
摘要:
Background.The outcome of orthotopic liver transplantation (OLTX) in patients retransplanted for severe hepatitis B virus (HBV) in the first allograft has been poor due to high rates of HBV reinfection and even more aggressive disease in the second graft. Recent data suggest that hepatitis B immunoglobulin (HBIg) given after transplantation can be successful in delaying or preventing HBV reinfection in patients transplanted for chronic hepatitis B cirrhosis. We report the successful retransplantation of patients who developed recurrent or de novo hepatitis B after OLTX.Methods.Using similar HBIg regimens, two centers retransplanted seven patients after they developed recurrent or de novo hepatitis B in the first allograft. At retransplantation all seven patients were HBs antigen (Ag) positive; four patients were positive for HBeAg and HBV DNA by immunoblot assay, two patients were negative for HBeAg and HBV DNA, and one patient was positive for HBV DNA and negative for HBeAg. All patients were either HDV Ag or anti-HDV negative. One patient was anti-HCV positive. All patients received HBIg infusions after retransplantation to maintain serum anti-HBs levels >500 IU/L indefinitely.Results.After retransplantation, six of seven patients are alive (86%): all are without evidence of HBV recurrence with serum negative for HBsAg, HBeAg, and HBV DNA by immunoblot assay. Liver biopsies are normal on routine studies with immunohistochemical stains for HBcAg and HBsAg also being negative. Mean follow-up of these six patients is 40.1 months (range 21-63 months). One patient (14%) developed HBV reinfection 7 months after his second transplant, in spite of maintaining target anti-HBs levels. He maintained stable liver function with minimal evidence of clinical hepatitis B, but died 8 months later from an unrelated stroke.Conclusions.We conclude that patients with recurrent or de novo hepatitis B after OLTX can be successfully retransplanted using aggressive immunoprophylaxis to prevent HBV reinfection. The failure of HBIg therapy in one patient underscores the need for other effective adjunctive anti-HBV modalities.
ISSN:0041-1337
出版商:OVID
年代:1997
数据来源: OVID
|
7. |
SUCCESSFUL LIVING RELATED LIVER TRANSPLANTATION IN AN ADULT WITH FULMINANT HEPATIC FAILURE |
|
Transplantation,
Volume 64,
Issue 3,
1997,
Page 415-417
Kato1 Tomoaki,
Nery1 Jose,
Morcos2 Jacques,
Gyamfi3 Anthony,
Ruiz4 Phillip,
Molina5 Enrique,
Tzakis1,6 Andreas,
Preview
|
|
摘要:
We report a case of an adult female who developed fulminant hepatic failure (FHF) during the second trimester of pregnancy and underwent a successful living related liver transplantation because no cadaveric donor was available during the development of life-threatening symptoms. A left lateral segment hepatic graft was procured from her brother, whose body weight was similar to hers. Her postoperative course was complicated by bleeding at the biliary anastomosis and subsequently by a biliary leak. Nevertheless, the complications were corrected surgically and the patient recovered well with a good quality of life 5 months after the transplant. This case suggests that living related liver transplantation should be considered more frequently for adult FHF patients. As the window of therapeutic opportunity is narrow for the dramatic condition of FHF, wide acceptance of this procedure will be of great benefit for the patients suffering from FHF.
ISSN:0041-1337
出版商:OVID
年代:1997
数据来源: OVID
|
8. |
SELECTION OF PROGNOSTIC FACTORS OF ACUTE HEPATITIS TYPE NON-A, NON-B FOR PATIENT LISTING FOR LIVER TRANSPLANTATION1 |
|
Transplantation,
Volume 64,
Issue 3,
1997,
Page 418-421
Kumashiro2 Ryukichi,
Sata Michio,
Koga Yuriko,
Suzuki Hiroshi,
Noguchi Kazunori,
Ishii Kunihide,
Kusaba Nobuhide,
Tanikawa Kyuichi,
Preview
|
|
摘要:
The aim of this study was to select prognostic factors from information available on admission in order to list patients for liver transplantation before the onset of hepatic encephalopathy in patients with fatal hepatitis type non-A, non-B. Information regarding patient profile and biochemical data obtained on admission was analyzed by multiple stepwise logistic regression, and independent prognostic factors related to death were selected. Four parameters were selected as independent prognostic factors. Patient age (over 50 years), serum total bilirubin level (over 10 mg/dl), peripheral leukocyte count, and prothrombin time were independently related to death. Positive predictive value, negative predictive value, and predictive accuracy were 0.86, 0.79, and 0.84, respectively. Our model is able to predict a patient's fatal outcome much earlier than other currently used models. It will be helpful for early referral to a transplant center.
ISSN:0041-1337
出版商:OVID
年代:1997
数据来源: OVID
|
9. |
HEPATITIS C VIRUS GENOTYPES IN LIVER TRANSPLANT RECIPIENTSImpact on Posttransplant Recurrence, Infections, Response to Interferon-α Therapy and Outcome |
|
Transplantation,
Volume 64,
Issue 3,
1997,
Page 422-426
Gayowski Timothy,
Singh1 Nina,
Marino Ignazio,
Vargas Hugo,
Wagener Marilyn,
Wannstedt Cheryl,
Morelli Franca,
Laskus Tomasz,
Fung John,
Rakela Jorge,
Starzl Thomas,
Preview
|
|
摘要:
Background.End-stage liver disease due to hepatitis C virus (HCV) is the most common indication for liver transplantation in U.S. veterans. We investigated the influence of HCV genotypes on the incidence and timing of recurrent HCV hepatitis, survival, infectious morbidity, and response to interferon-α therapy in this unique patient population.Methods.HCV genotype was determined by direct sequencing of the NS5 region of HCV with type-specific primers.Results.Genotype 1a (66%, 32/47) was the predominant genotype. Type 1b was found in 25% (12/47) of patients and type 2b was found in 9% (4/47). Histopathologically recurrent HCV hepatitis developed in 53% (25/47) of the patients after transplantation. This group included 45% (14/31) of the patients with type 1a, 67% (8/12) of the patients with type 1b, and 25% (1/4) of the patients with type 2b (P>0.5). The time to recurrence and the severity of HCV recurrence as defined by aminotransferase levels or Knodell scores were not different among the three genotypes. There was a trend toward a higher incidence of major infections in patients with type 1b (75%) versus type 1a (48%) and type 2b (50%) (P=0.11). The response to interferon-α therapy did not differe significantly among the genotypes. Mortality at 5 years was 16% (5/31) in patients with genotype 1a, 42% (5/12) in patients with genotype 1b, and 50% (2/4) in patients with genotype 2b (P=0.06).Conclusions.The incidence, time to recurrence, and response to interferon-α therapy did not differ between the various genotypes in our liver transplant recipients. However, there was a trend toward higher infectious morbidity and overall mortality in patients with genotype 1b after transplantation.
ISSN:0041-1337
出版商:OVID
年代:1997
数据来源: OVID
|
10. |
PERIPHERAL BLOOD MICROCHIMERISM IN HUMAN LIVER AND RENAL TRANSPLANT RECIPIENTSRejection Despite Donor-Specific Chimerism1 |
|
Transplantation,
Volume 64,
Issue 3,
1997,
Page 427-432
Sivasai Krovvidi,
Alevy Yael,
Duffy Brian,
Brennan Daniel,
Singer Gary,
Shenoy Surendra,
Lowell Jeffrey,
Howard Todd,
Mohanakumar2 T.,
Preview
|
|
摘要:
Background.Development of donor-specific microchimerism (DSM) has been proposed as one of the possible mechanisms for induction and maintenance of allograft tolerance. The aim of this study was to determine: (1) the state of DSM in liver transplant (LTx) and renal transplant (RTx) recipients, (2) whether the persistent presence of an allograft is a requirement for maintenance of chimerism, and (3) whether donor-specific blood transfusions (DST) facilitate chimerism development in RTx recipients and whether this correlates with allograft function.Methods.Qualitative and quantitative analysis of DSM in peripheral blood of LTx and RTx recipients was assessed by polymerase chain reaction and competitive polymerase chain reaction using HLA-DR probes for mismatched antigens between the donor and recipient.Results.LTx recipients (11 of 12) who had or were having rejection were positive for DSM in circulation compared with 4 of 11 with normal allograft function (P<0.01). The number of donor cells did not correlate with allograft function. LTx recipients (4 of 4) who lost their first allograft and underwent retransplantation retained DSM for the first donors. RTx recipients who received DST (8 of 8) were positive for DSM compared with 6 of 12 of nontransfused recipients (P<0.045).Conclusions.The results suggest that LTx and RTx recipients undergo rejection despite DSM. The development of DSM may not be a prerequisite for normal allograft function. Once DSM is established, the presence of the allograft is not required for maintenance of chimerism. DST facilitated the development of DSM in RTx recipients. Direct correlation was not observed between the development of DSM and allograft function in either DST or nontransfused RTx recipients.
ISSN:0041-1337
出版商:OVID
年代:1997
数据来源: OVID
|
|